Senphonix brings together operators who have successfully built and commercialized products and services in healthcare, the scientist who invented the core technology, the engineers who built the software stack, and advisors who have carried medical devices through regulatory clearance and into health systems.


“When it was time to select the startup team, we went with the people we had done great things with before." - Mike Haldane, Co-CEO
Built by people who had done it before.
Co-founders John Grant and Mike Haldane started Senphonix after years of working alongside each other at 3M. When they set out to build the team, they went to the people that had, in Mike’s words, “done great things before.” The result is a group that has lived the problems health systems face, from the clinical floor to the balance sheet, and that has shipped and supported real products and services into regulated markets.
Depth where it counts.
SleeveSense™ sits at the intersection of hardware, software, clinical evidence, regulation, and manufacturing, so the team is built to match. Philipp Gutruf, who invented the core technology, leads biomedical engineering with the Gutruf Lab at the University of Arizona. Mark Koppel advises on driving adoption in clinical environments. Scott Kulstad shares his experience as a health system executive to provide guidance on healthcare policy and regulatory relations. Wayne Metcalfe leads supply chain and manufacturing scale-up. Day to day, the company is run by its founders and a senior software engineering team that owns the platform from the cloud to the device.
Clinically practical. Technically resilient. Economically viable.
Those three tests guide every decision at Senphonix. A technology only matters if clinicians will actually use it, if it holds up in the real world, and if a health system can afford to adopt it. We build to all three at once.
SleeveSense™ will be available upon FDA clearance, which is expected in 2027.
Senphonix is a Delaware C-Corp., with offices in Minnesota and Arizona. For more information, contact us at info@senphonix.com or 612-913-0607; or follow us on LinkedIn. Copyright © 2026 Senphonix, Inc. - All Rights Reserved. Logos and trademarks are the property of their respective owners. All quotes herein are drawn from anonymous responses to two MarketWise Advising ("MarketWise") national studies, commissioned by Senphonix; some quotes were lightly edited for brevity.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.